Literature DB >> 23551093

Phosphoinositide 3-kinase and INPP4B in human breast cancer.

Micka C Bertucci1, Christina A Mitchell.   

Abstract

The PI3K/Akt signaling pathway is frequently increased in many human cancers, including breast cancer. Recent studies have identified INPP4B, which inhibits PI3K signaling, as an emerging tumor suppressor in breast cancer. This short review discusses these issues and the possibility that INPP4B is an important regulator in many cancers.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551093     DOI: 10.1111/nyas.12036

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  19 in total

1.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Authors:  Ruth Perets; Gregory A Wyant; Katherine W Muto; Jonathan G Bijron; Barish B Poole; Kenneth T Chin; Jin Yun H Chen; Anders W Ohman; Corey D Stepule; Soongu Kwak; Alison M Karst; Michelle S Hirsch; Sunita R Setlur; Christopher P Crum; Daniela M Dinulescu; Ronny Drapkin
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

2.  Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.

Authors:  Petra den Hollander; Kathryn Rawls; Anna Tsimelzon; Jonathan Shepherd; Abhijit Mazumdar; Jamal Hill; Suzanne A W Fuqua; Jenny C Chang; C Kent Osborne; Susan G Hilsenbeck; Gordon B Mills; Powel H Brown
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

3.  INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.

Authors:  Ying Sun; Huan Ding; Xinguang Liu; Xiaoqing Li; Li Li
Journal:  Tumour Biol       Date:  2014-01-14

4.  The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: Functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines.

Authors:  Ognian C Ikonomov; Catherine Filios; Diego Sbrissa; Xuequn Chen; Assia Shisheva
Journal:  Biochem Biophys Res Commun       Date:  2013-09-23       Impact factor: 3.575

Review 5.  The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.

Authors:  XueQiao Liu; Jeffrey I Cohen
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

Review 6.  Breast Cancer Genomics: Primary and Most Common Metastases.

Authors:  Caroline Bennett; Caleb Carroll; Cooper Wright; Barbara Awad; Jeong Mi Park; Meagan Farmer; Elizabeth Bryce Brown; Alexis Heatherly; Stefanie Woodard
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

7.  INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.

Authors:  Ping Wang; Dan Ma; Jishi Wang; Qin Fang; Rui Gao; Weibing Wu; Lu Cao; Xiuying Hu; Jiangyuan Zhao; Yan Li
Journal:  Tumour Biol       Date:  2016-06-24

Review 8.  The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers.

Authors:  Elisavet Paplomata; Ruth O'Regan
Journal:  Ther Adv Med Oncol       Date:  2014-07       Impact factor: 8.168

Review 9.  Discovery and development of small molecule SHIP phosphatase modulators.

Authors:  William G Kerr; John D Chisholm; Dennis R Viernes; Lydia B Choi
Journal:  Med Res Rev       Date:  2013-12-02       Impact factor: 12.944

Review 10.  Targeting SHIP1 and SHIP2 in Cancer.

Authors:  Chiara Pedicone; Shea T Meyer; John D Chisholm; William G Kerr
Journal:  Cancers (Basel)       Date:  2021-02-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.